| Title |
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
|
|---|---|
| Published in |
npj Breast Cancer, January 2019
|
| DOI | 10.1038/s41523-018-0097-z |
| Pubmed ID | |
| Authors |
Stephen Johnston, Miguel Martin, Angelo Di Leo, Seock-Ah Im, Ahmad Awada, Tammy Forrester, Martin Frenzel, Molly C. Hardebeck, Joanne Cox, Susana Barriga, Masakazu Toi, Hiroji Iwata, Matthew P. Goetz |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 25% |
| Unknown | 6 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 379 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 379 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 51 | 13% |
| Other | 39 | 10% |
| Student > Bachelor | 33 | 9% |
| Student > Ph. D. Student | 27 | 7% |
| Student > Master | 26 | 7% |
| Other | 49 | 13% |
| Unknown | 154 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 116 | 31% |
| Biochemistry, Genetics and Molecular Biology | 26 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 5% |
| Agricultural and Biological Sciences | 9 | 2% |
| Nursing and Health Professions | 8 | 2% |
| Other | 32 | 8% |
| Unknown | 169 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2024.
All research outputs
#697,548
of 23,342,232 outputs
Outputs from npj Breast Cancer
#32
of 512 outputs
Outputs of similar age
#17,851
of 439,467 outputs
Outputs of similar age from npj Breast Cancer
#2
of 12 outputs
Altmetric has tracked 23,342,232 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 512 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.7. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,467 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.